TNFSF11 and breast carcinoma: Intriguingly, we rather observed a progesterone-independent reduction in RANKL and increase in OPG serum levels with breast cancer manifestation resulting in significant decrease in the RANKL-to-OPG ratio compared to UKCTOCS participants who never developed breast cancer (Figure 3A).